Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.88
+0.16 (1.49%)
Oct 14, 2026, 4:08 PM HKT

HKG:2096 Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, HKG:2096 stock has a consensus rating of "Strong Buy" and an average price target of $19.45. The average 1-year stock price forecast is 78.77% higher than the current stock price, while the lowest is $16.66 (+53.12%) and the highest is $21.50 (+97.61%).

Price Target: $19.45 (+78.77%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$16.66$19.45$20.20$21.50
Change+53.12%+78.77%+85.66%+97.61%
* Price targets were last updated on Sep 2, 2026.

Analyst Ratings

The average analyst rating for HKG:2096 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy444444
Buy011111
Hold111111
Sell000000
Strong Sell000000
Total566666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Huatai Securities
No rating
Huatai Securities
Buy
Maintains
$21.46
BuyMaintains$21.46+97.24%Sep 2, 2026
Unknown Analyst
BOCOM International Holdings Company
No rating
BOCOM International Holdings Company
Buy
Maintains
$20.00
BuyMaintains$20.00+83.82%Aug 26, 2026
Unknown Analyst
Bank of China
No rating
Bank of China
Buy
Maintains
$17.00
BuyMaintains$17.00+56.25%Aug 3, 2026
Unknown Analyst
UBS
No rating
UBS
Buy
Maintains
$16.30
BuyMaintains$16.30+49.82%Jul 31, 2026
Unknown Analyst
Citic Securities
No rating
Citic Securities
Buy
Maintains
$20.00
BuyMaintains$20.00+83.82%Jun 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
10.40B
from 7.73B
Increased by 34.56%
Revenue Next Year
12.11B
from 10.40B
Increased by 16.41%
EPS This Year
0.68
from 0.51
Increased by 31.59%
EPS Next Year
0.78
from 0.68
Increased by 15.88%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
5.00B6.32B6.61B6.64B7.73B10.40B
Revenue Growth
10.89%26.49%4.49%0.42%16.52%34.56%
Gross Profit
3.92B5.00B4.98B5.32B6.31B8.63B
Gross Margin
78.40%79.01%75.43%80.25%81.61%82.94%
Operating Income
233.33M606.34M710.84M1.12B1.42B1.91B
Net Income
1.51B930.87M714.76M722.00M1.34B1.77B
EPS
----0.510.68
EPS Growth
----77.34%31.59%
Forward PE
26.6329.0412.1114.3516.5813.71
Dividend / Share
0.150.160.160.160.180.36
Dividend Growth
-6.67%--12.50%100.29%
Free Cash Flow
-----618.19M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High10.7B
Avg10.4B
Low10.2B

Revenue Growth

Revenue Growth202620272028
High
38.1%
Avg
34.6%
Low
31.8%

EPS Forecast

EPS202620272028
High0.70
Avg0.68
Low0.65

EPS Growth

EPS Growth202620272028
High
36.1%
Avg
31.6%
Low
26.4%